ESC 365 - SurHyb Trial: Hybrid Ablation in Persistent Atrial Fibrillation

ESC Professional Premium Access

SurHyb Trial: Hybrid Ablation in Persistent Atrial Fibrillation

Session: Late-breaking science on atrial fibrillation

Topic: Rhythm Control, Hybrid Therapy

Speaker: Professor A. Bulava (Ceske Budejovice, CZ)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Alan Bulava

Regional Hospital of Ceske Budejovice, Ceske Budejovice (Czechia)

3 presentations

0 follower

3 more presentations in this session

SS-AFRF - Shensong Yangxin capsule regulates persistent atrial fibrillation after RFCA

Speaker: Doctor H. Huang (Wuhan, CN)

CRALAL: Addtional right atrial ablation after cryoablation for AF

Speaker: Doctor D. Kim (Seoul, KR)

COMPARE CRYO - an RCT of PolarX vs. Arctic Front Cryo PVI with ICM endpoint assessment

Speaker: Professor T. Reichlin (Bern, CH)

Access the full session

Late-breaking science on atrial fibrillation

Speakers: Professor A. Bulava, Doctor H. Huang, Doctor D. Kim, Professor T. Reichlin

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources